186 related articles for article (PubMed ID: 28528606)
41. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.
Yu HS
J Biomed Sci; 2002; 9(6 Pt 2):564-73. PubMed ID: 12432222
[TBL] [Abstract][Full Text] [Related]
42. Melanocytes: the new Black.
Goding CR
Int J Biochem Cell Biol; 2007; 39(2):275-9. PubMed ID: 17095283
[TBL] [Abstract][Full Text] [Related]
43. Effect of Dickkopf1 on the senescence of melanocytes: in vitro study.
Rani S; Chauhan R; Parsad D; Kumar R
Arch Dermatol Res; 2018 May; 310(4):343-350. PubMed ID: 29442138
[TBL] [Abstract][Full Text] [Related]
44. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo.
Zailaie MZ
Saudi Med J; 2004 Nov; 25(11):1656-63. PubMed ID: 15573197
[TBL] [Abstract][Full Text] [Related]
45. Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo.
Chaudhary A; Patel M; Singh S
Curr Drug Targets; 2022; 23(13):1219-1238. PubMed ID: 35388753
[TBL] [Abstract][Full Text] [Related]
46. Activation of melanoblasts and melanocytes after treatment with monochromatic excimer light and narrowband-ultraviolet B of skin of vitiligo patients.
Hirobe T; Enami H
Int J Dermatol; 2019 Feb; 58(2):210-217. PubMed ID: 30191560
[TBL] [Abstract][Full Text] [Related]
47. Neural differentiation of melanocytes in vitiliginous skin.
Iyengar B; Misra RS
Acta Anat (Basel); 1988; 133(1):62-5. PubMed ID: 3145667
[TBL] [Abstract][Full Text] [Related]
48. [Intravenous immunoglobulin therapy in Vogt-Koyanagi-Harada syndrome].
González-Delgado M; González C; Blázquez JI; Salas-Puig J; Castro J; Hernández-Lahoz C
Neurologia; 2004 Sep; 19(7):401-3. PubMed ID: 15273890
[TBL] [Abstract][Full Text] [Related]
49. Successful culture of adult human melanocytes obtained from normal and vitiligo donors.
Medrano EE; Nordlund JJ
J Invest Dermatol; 1990 Oct; 95(4):441-5. PubMed ID: 1698887
[TBL] [Abstract][Full Text] [Related]
50. [Vogt-Koyanagi-Harada disease. About two observations (author's transl)].
Bazex A; Balas D; Bazex J; Bec P; Solier M; Secheyron P
Ann Dermatol Venereol; 1977 Dec; 104(12):849-53. PubMed ID: 613952
[TBL] [Abstract][Full Text] [Related]
51. Vogt-Koyanagi-Harada syndrome and psoriasis.
Howsden SM; Herndon JH; Freeman RG
Arch Dermatol; 1973 Sep; 108(3):395-8. PubMed ID: 4580973
[No Abstract] [Full Text] [Related]
52. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
Vanscheidt W; Hunziker T
Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
[TBL] [Abstract][Full Text] [Related]
53. Uveomeningoencephalic syndrome (Vogt-Koyanagi-Harada).
Rosenthal AL
Cutis; 1980 Apr; 25(4):363-6, 370. PubMed ID: 7363662
[No Abstract] [Full Text] [Related]
54. Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.
Cuevas M; de-la-Torre A; Córdoba A
Ocul Immunol Inflamm; 2018; 26(7):1101-1106. PubMed ID: 28548582
[TBL] [Abstract][Full Text] [Related]
55. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo.
Jimbow K; Chen H; Park JS; Thomas PD
Br J Dermatol; 2001 Jan; 144(1):55-65. PubMed ID: 11167683
[TBL] [Abstract][Full Text] [Related]
56. [Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease].
Zheng YZ
Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):572-6. PubMed ID: 22943816
[TBL] [Abstract][Full Text] [Related]
57. Growth of human melanocytes from suction blister of localized vitiligo patient and from foreskins of newborns and adults by modified culture medium.
Jee SH; Kuo YF; Wu YC; Chang CH; Kuo WL; Lü YC
J Formos Med Assoc; 1993 Jan; 92(1):7-14. PubMed ID: 8099831
[TBL] [Abstract][Full Text] [Related]
58. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
59. [Vogt-Koyanagi-Harada syndrome. Eight cases].
Alaoui FZ; Benamour S; El Kabli H; Amraoui A
Rev Med Interne; 2007 Apr; 28(4):250-4. PubMed ID: 17350144
[TBL] [Abstract][Full Text] [Related]
60. Melanocyte destruction and repopulation in vitiligo.
Norris DA; Horikawa T; Morelli JG
Pigment Cell Res; 1994 Aug; 7(4):193-203. PubMed ID: 7855062
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
